69 Impact of a Pharmacist-Led Vaccine Recommendation Program for Pediatric Kidney Transplant Candidates

Wednesday, May 18, 2016
Clarice Carthon, Pharm.D., BCPS, Reed Hall, Pharm.D., BCPS, Pamela Maxwell, Pharm.D., BCPS and Barrett Crowther, Pharm.D., BCPS
University Health System, San Antonio, TX
Introduction: Previous studies have shown that a significant proportion of pediatric transplant recipients have incomplete age-specific vaccination schedules at the time of transplantation. Currently, no published studies have described the role of a transplant pharmacist in improving immunization rates for this vulnerable population.

Objectives: To evaluate the impact of transplant pharmacist interventions on the completion rate of vaccination schedules at the time of transplant. 

Study Design: Single-center, retrospective study

Methods: Pediatric kidney transplant recipients with available vaccine records who underwent transplantation between 1/1/12 and 9/30/15 were included. We compared patients who received pharmacist-led vaccination recommendations prior to transplant to a control group without pharmacist recommendations. Intervention began 1/1/14 and included assessment of vaccination status at time of initial evaluation according to the CDC immunization schedule and provision of recommendations for a vaccination catch-up schedule.

Results: Forty-seven pediatric patients were included. The intervention and control groups included 29 and 18 patients, respectively. Overall, the mean age was 11 (range 1-18) years at transplant and a majority was Hispanic (60%), female (53%), and recipients of a deceased donor transplant (89%). Baseline characteristics were similar between groups. The median percentage of up-to-date vaccinations at the time of evaluation was 80% in both groups [p=0.62]. The median percentage of up-to-date vaccinations at the time of transplant was significantly higher in the intervention group (90%; IQR 82-100%) vs. the control group (80%; IQR 71-80%) [p= 0.0008]. No patient was admitted for a vaccine-preventable infection within 6 months post-transplant.

Conclusions:

In this cohort, not all patients were fully immunized at the time of evaluation; however, with pharmacist intervention, significantly more patients were up-to-date with vaccination schedules at the time of transplant. These results suggest that a transplant pharmacist may serve as a valuable resource to increase immunization schedule compliance between time of evaluation and transplantation.